Laszlovszky, István
Barabássy, Ágota
Németh, György
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Documents that mention this clinical trial
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
https://doi.org/10.1007/s12325-021-01797-5
Funding for this research was provided by:
Gedeon Richter
Article History
Received: 14 April 2021
Accepted: 15 May 2021
First Online: 6 June 2021